Squarepoint Ops LLC Global Blood Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $662,912 - $1.11 Million	29,727 Added 39.33%	105,305 $3.36 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $825,560 - $1.14 Million	32,148 Added 74.02%	75,578 $2.62 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $208,512 - $337,137	-8,374 Reduced 16.16%	43,430 $1.27 Million
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $980,266 - $1.44 Million	38,472 Added 288.57%	51,804 $1.32 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $35,770 - $47,848	1,102 Added 9.01%	13,332 $467,000
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $186,483 - $243,520	-4,789 Reduced 28.14%	12,230 $498,000
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $405,565 - $686,930	10,772 Added 172.43%	17,019 $737,000
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $2.13 Million - $3.01 Million	-40,344 Reduced 86.59%	6,247 $344,000
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $1.8 Million - $3.02 Million	36,878 Added 379.68%	46,591 $2.94 Million
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $374,729 - $783,230	-8,982 Reduced 48.04%	9,713 $496,000
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $1.97 Million - $3.52 Million	-43,051 Reduced 69.72%	18,695 $1.49 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $164,937 - $210,618	-3,637 Reduced 5.56%	61,746 $3 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $2.34 Million - $2.82 Million	44,483 Added 212.84%	65,383 $3.44 Million
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $230,342 - $308,044	5,760 Added 38.04%	20,900 $1.11 Million
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $374,064 - $553,506	-11,860 Reduced 43.93%	15,140 $621,000
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $106,400 - $143,080	-2,800 Reduced 9.4%	27,000 $1.03 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $441,180 - $571,710	11,400 Added 61.96%	29,800 $1.35 Million
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $930,362 - $1.55 Million	-23,494 Reduced 56.08%	18,400 $889,000
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $1.24 Million - $1.91 Million	41,894	41,894 $1.65 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account